These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23564459)

  • 21. Phosphatidylinositol 4,5-bisphosphate (PIP2) modulation of ATP and pH sensitivity in Kir channels. A tale of an active and a silent PIP2 site in the N terminus.
    Schulze D; Krauter T; Fritzenschaft H; Soom M; Baukrowitz T
    J Biol Chem; 2003 Mar; 278(12):10500-5. PubMed ID: 12514171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arachidonic acid activates Kir2.3 channels by enhancing channel-phosphatidyl-inositol 4,5-bisphosphate interactions.
    Wang C; Mirshahi UL; Liu B; Jia Z; Mirshahi T; Zhang H
    Mol Pharmacol; 2008 Apr; 73(4):1185-94. PubMed ID: 18202303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Crosstalk to Synergism: The Combined Effect of Cholesterol and PI(4,5)P
    Bukiya AN; Rosenhouse-Dantsker A
    Adv Exp Med Biol; 2023; 1422():169-191. PubMed ID: 36988881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol inhibits Kir2.3 channels by interference with PIP₂-channel interaction.
    Ferrer T; Ponce-Balbuena D; López-Izquierdo A; Aréchiga-Figueroa IA; de Boer TP; van der Heyden MA; Sánchez-Chapula JA
    Eur J Pharmacol; 2011 Oct; 668(1-2):72-7. PubMed ID: 21663737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stoichiometry of Kir channels with phosphatidylinositol bisphosphate.
    Jin T; Sui JL; Rosenhouse-Dantsker A; Chan KW; Jan LY; Logothetis DE
    Channels (Austin); 2008; 2(1):19-33. PubMed ID: 18690051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.
    Pegan S; Arrabit C; Zhou W; Kwiatkowski W; Collins A; Slesinger PA; Choe S
    Nat Neurosci; 2005 Mar; 8(3):279-87. PubMed ID: 15723059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atomistic basis of opening and conduction in mammalian inward rectifier potassium (Kir2.2) channels.
    Zangerl-Plessl EM; Lee SJ; Maksaev G; Bernsteiner H; Ren F; Yuan P; Stary-Weinzinger A; Nichols CG
    J Gen Physiol; 2020 Jan; 152(1):. PubMed ID: 31744859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-mode phospholipid regulation of human inward rectifying potassium channels.
    Cheng WWL; D'Avanzo N; Doyle DA; Nichols CG
    Biophys J; 2011 Feb; 100(3):620-628. PubMed ID: 21281576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
    Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
    J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diverse Kir modulators act in close proximity to residues implicated in phosphoinositide binding.
    Logothetis DE; Lupyan D; Rosenhouse-Dantsker A
    J Physiol; 2007 Aug; 582(Pt 3):953-65. PubMed ID: 17495041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long chain CoA esters as competitive antagonists of phosphatidylinositol 4,5-bisphosphate activation in Kir channels.
    Rapedius M; Soom M; Shumilina E; Schulze D; Schönherr R; Kirsch C; Lang F; Tucker SJ; Baukrowitz T
    J Biol Chem; 2005 Sep; 280(35):30760-7. PubMed ID: 15980413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of inwardly rectifying potassium (Kir) channels by phosphatidylinosital-4,5-bisphosphate (PIP2): interaction with other regulatory ligands.
    Xie LH; John SA; Ribalet B; Weiss JN
    Prog Biophys Mol Biol; 2007 Jul; 94(3):320-35. PubMed ID: 16837026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining how multiple lipid species interact with inward rectifier potassium (Kir2) channels.
    Duncan AL; Corey RA; Sansom MSP
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7803-7813. PubMed ID: 32213593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoinositide regulation of inward rectifier potassium (Kir) channels.
    Fürst O; Mondou B; D'Avanzo N
    Front Physiol; 2014 Jan; 4():404. PubMed ID: 24409153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of control of inward rectifier Kir2 channel gating by bulk anionic phospholipids.
    Lee SJ; Ren F; Zangerl-Plessl EM; Heyman S; Stary-Weinzinger A; Yuan P; Nichols CG
    J Gen Physiol; 2016 Sep; 148(3):227-37. PubMed ID: 27527100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.
    López-Izquierdo A; Aréchiga-Figueroa IA; Moreno-Galindo EG; Ponce-Balbuena D; Rodríguez-Martínez M; Ferrer-Villada T; Rodríguez-Menchaca AA; van der Heyden MA; Sánchez-Chapula JA
    Pflugers Arch; 2011 Oct; 462(4):505-17. PubMed ID: 21779761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A discrete alcohol pocket involved in GIRK channel activation.
    Aryal P; Dvir H; Choe S; Slesinger PA
    Nat Neurosci; 2009 Aug; 12(8):988-95. PubMed ID: 19561601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the ATP-sensitive K channel Kir6.2 by ATP and PIP(2).
    Ribalet B; John SA; Xie LH; Weiss JN
    J Mol Cell Cardiol; 2005 Jul; 39(1):71-7. PubMed ID: 15978904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies.
    Lopes CM; Zhang H; Rohacs T; Jin T; Yang J; Logothetis DE
    Neuron; 2002 Jun; 34(6):933-44. PubMed ID: 12086641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of pH and PIP2 gating in heteromeric Kir4.1/Kir5.1 channels by H-Bonding at the helix-bundle crossing.
    Rapedius M; Paynter JJ; Fowler PW; Shang L; Sansom MS; Tucker SJ; Baukrowitz T
    Channels (Austin); 2007; 1(5):327-30. PubMed ID: 18690035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.